Houston Institute For Clinical Research is categorized under Commercial Medical Research in Houston, TX and active since 1985.
Houston Institute For Clinical Research was established in 1985, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Frank Lanza at the company’s single location by writing to 7777 Suthwest Freeway # 720, Houston, Texas TX 77074 or by phoning (713) 988-2615. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Houston Institute For Clinical Research |
Contact Person: | Frank Lanza |
Address: | 7777 Suthwest Freeway # 720, Houston, Texas 77074 |
Phone Number: | (713) 988-2615 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 1985 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Commercial Medical Research |
SIC Code: | 8731 |
NAICS Code: | 541712 |
Share This Business: |
Houston Institute For Clinical Research was started in 1985 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Frank Lanza for inquiries that concern Houston Institute For Clinical Research by calling the company number (713) 988-2615, as your correspondence is most welcome. Additionally, the physical location of the single location of Houston Institute For Clinical Research can be found at the coordinates 29.694806,-95.523121 as well as the street address 7777 Suthwest Freeway # 720 in Houston, Texas 77074.
For its online presence, you may visit Houston Institute For Clinical Research’s website at and engage with its social media outlets through on Twitter and on Facebook.